
Angiotensin II acetate
CAS No. 68521-88-0
Angiotensin II acetate ( Angiotensin II human acetate,Ang II acetate,DRVYIHPF acetate )
产品货号. M22272 CAS No. 68521-88-0
醋酸血管紧张素II是一种血管收缩剂,主要作用于AT1受体。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥267 | 有现货 |
![]() ![]() |
10MG | ¥437 | 有现货 |
![]() ![]() |
25MG | ¥988 | 有现货 |
![]() ![]() |
50MG | ¥1871 | 有现货 |
![]() ![]() |
100MG | ¥2843 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Angiotensin II acetate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述醋酸血管紧张素II是一种血管收缩剂,主要作用于AT1受体。
-
产品描述Angiotensin II acetate is a vasoconstrictor that mainly acts on the AT1 receptor.(In Vitro):Most of the known actions of Angiotensin II (Ang II) human acetate are mediated by AT1 receptors, the AT2 receptor contributes to the regulation of blood pressure and renal function.Angiotensin II human acetate raises blood pressure (BP) by a number of actions, the most important ones being vasoconstriction, sympathetic nervous stimulation, increased aldosterone biosynthesis and renal actions. Other Angiotensin II human acetate actions include induction of growth, cell migration, and mitosis of vascular smooth muscle cells, increased synthesis of collagen type I and III in fibroblasts, leading to thickening of the vascular wall and myocardium, and fibrosis. These actions are mediated by type 1 Ang II receptors (AT1).Angiotensin II (1 nM) induces the expression of LOX-1 and VEGF and enhances capillary formation from human coronary endothelial cells in Matrigel assay. Angiotensin II -mediated expression of LOX-1 and VEGF, capillary formation, intracellular reactive oxygen species generation, and phosphorylation of p38 as well as p44/42 mitogen-activated protein kinases, were suppressed by anti-LOX-1 antibody, nicotinamide-adenine dinucleotide phosphate oxidase inhibitor apocynin and the Ang II type 1 receptor blocker Losartan, but not by the Ang II type 2 receptor blocker PD123319.(In Vivo):Angiotensin II human (5 mL of 1 nM; intraperitoneal injection; 200-250 g Sprague-Dawley rats) acetate induces a significant neutrophil recruitment that was maximal at 4 hours and had resolved by 24 hours.To distinguish the AT1 receptor population that is critical for the pathogenesis of hypertension, osmotic minipumps are implanted s.c. into each animal to infuse Angiotensin II human (1000 ng/kg/min) acetate continuously for 4 weeks. Angiotensin II human acetate causes hypertension by activating AT1 receptors in the kidney promoting sodium reabsorption.
-
体外实验Most of the known actions of Angiotensin II (Ang II) human acetate are mediated by AT1 receptors, the AT2 receptor contributes to the regulation of blood pressure and renal function. Angiotensin II human acetate raises blood pressure (BP) by a number of actions, the most important ones being vasoconstriction, sympathetic nervous stimulation, increased aldosterone biosynthesis and renal actions. Other Angiotensin II human acetate actions include induction of growth, cell migration, and mitosis of vascular smooth muscle cells, increased synthesis of collagen type I and III in fibroblasts, leading to thickening of the vascular wall and myocardium, and fibrosis. These actions are mediated by type 1 Ang II receptors (AT1). Angiotensin II (1 nM) induces the expression of LOX-1 and VEGF and enhances capillary formation from human coronary endothelial cells in Matrigel assay. Angiotensin II -mediated expression of LOX-1 and VEGF, capillary formation, intracellular reactive oxygen species generation, and phosphorylation of p38 as well as p44/42 mitogen-activated protein kinases, were suppressed by anti-LOX-1 antibody, nicotinamide-adenine dinucleotide phosphate oxidase inhibitor apocynin and the Ang II type 1 receptor blocker Losartan, but not by the Ang II type 2 receptor blocker PD123319.
-
体内实验Angiotensin II human (5 mL of 1 nM; intraperitoneal injection; 200-250 g Sprague-Dawley rats) acetate induces a significant neutrophil recruitment that was maximal at 4 hours and had resolved by 24 hours.To distinguish the AT1 receptor population that is critical for the pathogenesis of hypertension, osmotic minipumps are implanted s.c. into each animal to infuse Angiotensin II human (1000 ng/kg/min) acetate continuously for 4 weeks. Angiotensin II human acetate causes hypertension by activating AT1 receptors in the kidney promoting sodium reabsorption.
-
同义词Angiotensin II human acetate,Ang II acetate,DRVYIHPF acetate
-
通路Endocrinology/Hormones
-
靶点RAAS
-
受体angiotensin AT1?receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number68521-88-0
-
分子量1106.2
-
分子式C52H75N13O14
-
纯度>98% (HPLC)
-
溶解度In Vitro:?H2O : 25 mg/mL (22.60 mM)
-
SMILESCC(O)=O.CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Fyhrquist F, et al. Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders. J Hum Hypertens. 1995 Nov;9 Suppl 5:S19-24.
产品手册




关联产品
-
OPHIOPOGONIN D
Ophiopogonin D 是一种天然产物,是一种 CYP2J3 诱导剂,可显着抑制 Ang II 诱导的 NF-κB 核转位。
-
Benazeprilat
Benazeprilat 是一种具有口服活性的贝那普利活性代谢物,贝那普利是一种具有抗高血压活性的含羧基血管紧张素转换酶 ACE 抑制剂。Benazeprilat 是一种公认的抗高血压剂,无论是单药研究还是与其他类别的药物(包括噻嗪类利尿剂和钙通道阻滞剂)联合使用。Benazeprilat 是减少与心血管风险和继发性终末器官损伤相关的各种病理的一线研究药物。
-
Aviptadil Acetate
Avitadilacetate 可诱导肺血管舒张并抑制血管 SMC 的增殖和血小板聚集。